As coronavirus restrictions drag on, Americans shift online spending from stockpiling to entertainment
In addition to the overall boom in e-commerce spending, sales data reveals that following an initial stockpiling of goods, many online shoppers have shifted their focus to entertainment products such as books and games as they adjust to the new normal of life in quarantine.
technology business-news business e-commerce coronavirus covid-19
GoogleRelated Articles
Elon Musk Gains $8 Billion to Become World’s Fourth-Richest Person
Elon Musk’s financial upswing shows no signs of slowing. The rise vaulted the Tesla co-founder past French luxury tycoon Bernard Arnault, the wealthiest non-American on the Bloomberg Billionaires Index. Musk’s fortune has grown by $57.2 billion this year, the second-biggest increase on the index after Amazon.com Inc. founder Jeff Bezos’s.
technology business markets wealth valuation sp-500-index amazoncom-inc tesla-inc pursuits elon-reeve-musk bernard-arnault mark-elliot-zuckerberg billionaires space-exploration-technologi
Bloomberg
Bank of England holds interest rate at 0.1%
In an important announcement on Thursday, the Bank of England held interest rates steady and maintained its existing level of asset purchases, as investors watched for signs that it is anticipating a slower economic recovery. The main lending rate was kept at 0.1%, as the central bank cut rates twice from 0.75% since the beginning of the coronavirus pandemic
rates coronavirus interest boe
CNBC
Zuckerberg says there's 'no end in sight' for Facebook employees working from home
Facebook CEO Mark Zuckerberg on Thursday said there is no timetable for when employees will return to the company's offices amid a continuing surge in Covid-19 cases in the U.S. Zuckerberg made his comments on a call with analysts about Facebook's second-quarter results, specifically criticizing the Trump Administration for its handling of the coronavirus.
facebook technology business mark
Cnbc
Moderna, Pfizer Start Decisive Covid Vaccine Trials
Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday. The trials, both announced on Monday, are the first late-stage studies supported by the Trump administration's effort to speed development of measures against the novel coronavirus.
vaccine coronavirus
Ndtv